Sofgen Pharma S.A. (PROCF)
OTCMKTS · Delayed Price · Currency is USD
0.1100
+0.1089 (9,900.00%)
Mar 24, 2026, 9:57 AM EST
Sofgen Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -68.3 | 40.34 | 36.13 | -106.99 | -10.45 |
Depreciation & Amortization | 15.71 | 14.67 | 16.84 | 15.11 | 16.48 |
Other Amortization | 4.33 | 3.53 | - | - | - |
Loss (Gain) From Sale of Assets | 5.24 | 0.62 | 0.64 | -0.48 | 0.3 |
Asset Writedown & Restructuring Costs | 1.98 | 13.75 | 6.02 | - | - |
Loss (Gain) From Sale of Investments | -12.65 | -11.19 | -61.8 | -4.51 | - |
Loss (Gain) on Equity Investments | 0.49 | -0.5 | 0.92 | 0.31 | -0.81 |
Provision & Write-off of Bad Debts | 3.36 | 2.93 | 2.67 | -0.82 | -1.92 |
Other Operating Activities | 52.16 | 19.82 | 36.2 | 164.35 | 53.18 |
Change in Accounts Receivable | 35.56 | -5.57 | -10.8 | -15.62 | 1.89 |
Change in Inventory | -2.38 | 6.59 | -34.11 | -20.43 | -0.9 |
Change in Accounts Payable | 38.38 | 32.51 | -30 | 20.98 | 11.8 |
Change in Income Taxes | 2.55 | -3.64 | -5.81 | -3.63 | -2.58 |
Change in Other Net Operating Assets | 11.99 | -6.21 | 58.65 | -12.81 | 3.93 |
Operating Cash Flow | 88.43 | 107.64 | 15.55 | 35.45 | 70.92 |
Operating Cash Flow Growth | -17.84% | 592.19% | -56.14% | -50.01% | 3.86% |
Capital Expenditures | -19.38 | -20.33 | -23.16 | -15.44 | -7.7 |
Sale of Property, Plant & Equipment | 0.04 | - | 1.68 | 0.95 | 0.63 |
Sale (Purchase) of Intangibles | -5.64 | -12.46 | -10.96 | -10.4 | -10.22 |
Other Investing Activities | -1.79 | -1.84 | 0.06 | 0.03 | 0.2 |
Investing Cash Flow | -26.76 | -34.63 | -32.38 | -24.86 | -17.09 |
Short-Term Debt Issued | - | - | 0.06 | - | 0.03 |
Long-Term Debt Issued | 86.68 | 83.25 | 136.26 | 280.79 | 106.74 |
Total Debt Issued | 86.68 | 83.25 | 136.32 | 280.79 | 106.77 |
Short-Term Debt Repaid | - | - | -7.19 | -9.15 | -5.86 |
Long-Term Debt Repaid | -141.32 | -143.95 | -131.6 | -281.16 | -126.32 |
Total Debt Repaid | -141.32 | -143.95 | -138.79 | -290.31 | -132.18 |
Net Debt Issued (Repaid) | -54.64 | -60.69 | -2.47 | -9.52 | -25.41 |
Issuance of Common Stock | 38.61 | - | - | - | - |
Repurchase of Common Stock | -0.82 | -2.18 | - | -45 | - |
Other Financing Activities | -33.56 | -34.95 | -10.33 | 112.36 | -15.1 |
Financing Cash Flow | -50.4 | -97.83 | -12.8 | 57.84 | -40.51 |
Foreign Exchange Rate Adjustments | 1.54 | -0.67 | 0.52 | -0.56 | -11.13 |
Net Cash Flow | 12.8 | -25.49 | -29.11 | 67.88 | 2.19 |
Free Cash Flow | 69.05 | 87.3 | -7.61 | 20.02 | 63.22 |
Free Cash Flow Growth | -20.90% | - | - | -68.34% | 11.93% |
Free Cash Flow Margin | 18.47% | 20.60% | -1.89% | 4.96% | 19.07% |
Free Cash Flow Per Share | 0.69 | 0.86 | -0.07 | 0.20 | 0.65 |
Cash Interest Paid | 33.56 | 34.83 | 10.03 | 17.43 | 16.94 |
Cash Income Tax Paid | 10.46 | 5.47 | 7.31 | 11.56 | 13.14 |
Levered Free Cash Flow | 20.92 | 13.1 | -52.35 | -21.16 | -28.65 |
Unlevered Free Cash Flow | 47.47 | 38.63 | -36.2 | 32.33 | 4.25 |
Change in Working Capital | 86.1 | 23.68 | -22.07 | -31.51 | 14.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.